Epizyme welcome to Ipsen
- 12 August 2022 - 1 mins read
Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.
22 July 2024
0 mins read
Financial results for the first half of 2024
31 May 2024
1 mins read
Our 2023 Integrated Annual Report is live!
19 April 2024
0 mins read
Q1 2024 sales update
15 March 2024
2 mins read
Applications now open for the 2024 Golden Ticket competition
08 February 2024
0 mins read
FY 2023 results announcement
20 November 2023
1 mins read
Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics
10 November 2023
1 mins read
Examining the European Pharma legislation: EFPIA publishes the Dolon Report
03 November 2023
0 mins read
Capital Markets Day 2023
23 October 2023
1 mins read
2023 year to date and third-quarter sales results
20 July 2023
1 mins read